Corline Biomedical Ab Stock Working Capital
| CLBIO Stock | SEK 6.40 0.14 2.24% |
Corline Biomedical AB fundamentals help investors to digest information that contributes to Corline Biomedical's financial success or failures. It also enables traders to predict the movement of Corline Stock. The fundamental analysis module provides a way to measure Corline Biomedical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Corline Biomedical stock.
Corline |
Corline Biomedical AB Company Working Capital Analysis
Corline Biomedical's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
| Competition |
In accordance with the company's disclosures, Corline Biomedical AB has a Working Capital of 0.0. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The working capital for all Sweden stocks is 100.0% higher than that of the company.
Corline Working Capital Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Corline Biomedical's direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Corline Biomedical could also be used in its relative valuation, which is a method of valuing Corline Biomedical by comparing valuation metrics of similar companies.Corline Biomedical is currently under evaluation in working capital category among its peers.
Corline Fundamentals
| Return On Equity | 0.0075 | |||
| Return On Asset | 0.0044 | |||
| Profit Margin | 0.02 % | |||
| Operating Margin | 0.02 % | |||
| Current Valuation | 178.43 M | |||
| Shares Outstanding | 21.49 M | |||
| Shares Owned By Insiders | 54.88 % | |||
| Shares Owned By Institutions | 14.21 % | |||
| Price To Earning | (19.42) X | |||
| Price To Book | 2.20 X | |||
| Price To Sales | 6.44 X | |||
| Revenue | 7.06 M | |||
| Gross Profit | 9.1 M | |||
| EBITDA | (6.88 M) | |||
| Net Income | (6.92 M) | |||
| Cash And Equivalents | 41.63 M | |||
| Cash Per Share | 1.45 X | |||
| Current Ratio | 3.99 X | |||
| Book Value Per Share | 4.38 X | |||
| Cash Flow From Operations | (4.83 M) | |||
| Earnings Per Share | 0.03 X | |||
| Target Price | 29.0 | |||
| Number Of Employees | 10 | |||
| Beta | 0.8 | |||
| Market Capitalization | 203.87 M | |||
| Total Asset | 101.66 M | |||
| Net Asset | 101.66 M |
About Corline Biomedical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Corline Biomedical AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Corline Biomedical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Corline Biomedical AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Corline Stock Analysis
When running Corline Biomedical's price analysis, check to measure Corline Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Corline Biomedical is operating at the current time. Most of Corline Biomedical's value examination focuses on studying past and present price action to predict the probability of Corline Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Corline Biomedical's price. Additionally, you may evaluate how the addition of Corline Biomedical to your portfolios can decrease your overall portfolio volatility.